Christopher A. Walsh

• Boston Children's Hospital

  Chief of genetics and genomics

Sources: reporter.nih.gov

• National Institute of Neurological Disorders and Stroke

  R01, Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage, R01NS032457, 1994–2030, 29 Jul 2026

• National Institute on Aging

  R01, Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis, R01AG078929, 2022–2027, 17 Jul 2026

• National Institute of Neurological Disorders and Stroke

  UH3, Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types, UH3NS132138, 2023–2028, 30 Mar 2026

• National Institute of Neurological Disorders and Stroke

  UH3, Detection and Characterization of Somatic Mutations in Human Tissue Utilizing Duplex-Consensus Sequencing, UH3NS132144, 2023–2028, 25 Feb 2026

• National Institute on Aging

  R01, Rates and mechanisms of age-related somatic mutation in normal and Alzheimer brain, R01AG070921, 2021–2026, 24 Mar 2025

• National Institute of Neurological Disorders and Stroke

  UG3, Detection and Characterization of Somatic Mutations in Human Tissue Utilizing Duplex-Consensus Sequencing, UG3NS132144, 2023–2025, 6 May 2024

• National Institute of Neurological Disorders and Stroke

  UG3, Development of an Efficient High Throughput Technique for the Identification of High-Impact Non-Coding Somatic Variants Across Multiple Tissue Types, UG3NS132138, 2023–2025, 23 Apr 2024

• National Institute on Aging

  R56, Role of clonal somatic mutations in microglia activation and Alzheimer’s disease, R56AG079857, 2023–2025, 31 Aug 2023

Sources: reporter.nih.gov